{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:58:19Z","timestamp":1790859499987,"version":"4.1.0"},"reference-count":132,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The expanding use of biologic and oral targeted therapies has transformed the management of psoriasis and atopic dermatitis. These agents are increasingly prescribed to patients with current malignancy, a history of malignancy or an increased cancer risk, populations typically excluded from clinical trials. In the absence of robust long\u2010term safety data, clinicians often rely on real\u2010world evidence to inform treatment decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To review the evidence regarding malignancy risk associated with biologic and oral targeted therapies used in psoriasis and atopic dermatitis and to provide expert consensus recommendations for patients with current malignancy, previous malignancy or increased risk of malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We describe the physiological roles of key immune pathways targeted in psoriasis and atopic dermatitis, as well as in cancer immunosurveillance, tumour progression and immune escape. We then summarize evidence from randomized controlled trials regarding the risk of de novo malignancy, followed by a synthesis of real\u2010world data addressing cancer recurrence and progression in patients treated with biologic and oral targeted therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Available evidence suggests that the overall malignancy risk associated with most biologic and oral targeted therapies used in psoriasis and atopic dermatitis is low, although differences between therapeutic classes may exist. Real\u2010world data remain limited for several therapeutic classes and in patients with active or previous malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on the available evidence, we present consensus\u2010based recommendations developed by a multidisciplinary expert panel convened by the Skin Inflammation &amp; Psoriasis International Network\u2013Fondation Ren\u00e9 Touraine (SPIN\u2010FRT). These recommendations aim to support treatment decisions by balancing disease control with potential cancer\u2010related risks while highlighting key evidence gaps.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.70634","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:56:52Z","timestamp":1786370212000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy:\n                    <scp>SPIN<\/scp>\n                    \u2010\n                    <scp>FRT<\/scp>\n                    recommendations"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-0870","authenticated-orcid":false,"given":"T.","family":"Torres","sequence":"first","affiliation":[{"name":"Department of Dermatology Centro Acad\u00e9mico Cl\u00ednico, ICBAS\/Santo Ant\u00f3nio  Porto Portugal"},{"name":"Institute of Biomedical Sciences Abel Salazar University of Porto  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. C.","family":"Brembilla","sequence":"additional","affiliation":[{"name":"Division of Dermatology and Venereology University Hospitals of Geneva  Geneva Switzerland"},{"name":"Department of Pathology and Immunology, Faculty of Medicine University of Geneva  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"King","sequence":"additional","affiliation":[{"name":"Dermatology Physicians of Connecticut  Fairfield Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-399X","authenticated-orcid":false,"given":"R.","family":"Chovatiya","sequence":"additional","affiliation":[{"name":"Rosalind Franklin University of Medicine and Science Chicago Medical School  North Chicago Illinois USA"},{"name":"Center for Medical Dermatology + Immunology Research  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. B.","family":"Warren","sequence":"additional","affiliation":[{"name":"Dermatology Centre, Northern Care Alliance NHS Foundation Trust &amp; Division of Musculoskeletal and Dermatological Sciences, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre University of Manchester  Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-6286","authenticated-orcid":false,"given":"C.","family":"Flohr","sequence":"additional","affiliation":[{"name":"St John's Institute of Dermatology King's College London and Guy's &amp; St Thomas' NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vestergaard","sequence":"additional","affiliation":[{"name":"Department of Dermatology Aarhus University Hospital  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9048-2044","authenticated-orcid":false,"given":"A. D.","family":"Irvine","sequence":"additional","affiliation":[{"name":"Clinical Medicine Trinity College Dublin  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-0771","authenticated-orcid":false,"given":"J. M.","family":"Carrascosa","sequence":"additional","affiliation":[{"name":"Hospital Universitari Germans Trias i Pujol UAB. IGTP  Badalona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-1545","authenticated-orcid":false,"given":"J. T.","family":"Maul","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital of Z\u00fcrich  Z\u00fcrich Switzerland"},{"name":"Faculty of Medicine University of Z\u00fcrich  Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9918-1144","authenticated-orcid":false,"given":"C. H.","family":"Smith","sequence":"additional","affiliation":[{"name":"St John's Institute of Dermatology King's College London and Guy's &amp; St Thomas' NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G.","family":"Langley","sequence":"additional","affiliation":[{"name":"Division of Clinical Dermatology &amp; Cutaneous Science Dalhousie University  Halifax Nova Scotia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cort\u00e9s","sequence":"additional","affiliation":[{"name":"International Breast Cancer Center (IBCC) Pangaea Oncology, Quiron Group  Barcelona Spain"},{"name":"IOB Madrid Institute of Oncology, Hospital Beata Mar\u00eda Ana  Madrid Spain"},{"name":"Oncology Department Hospital Universitario Torrej\u00f3n, Ribera Group  Madrid Spain"},{"name":"Faculty of Biomedical and Health Sciences, Department of Medicine Universidad Europea de Madrid  Madrid Spain"},{"name":"Medica Scientia Innovation Research (MEDSIR)  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2585-6633","authenticated-orcid":false,"given":"V.","family":"Sibaud","sequence":"additional","affiliation":[{"name":"Department of Oncodermatology Cancer University Institute, Claudius Regaud Oncopole  Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tha\u00e7i","sequence":"additional","affiliation":[{"name":"Institute and Comprehensive Center for Inflammation Medicine University of L\u00fcbeck  L\u00fcbeck Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H.","family":"Boehncke","sequence":"additional","affiliation":[{"name":"Division of Dermatology and Venereology University Hospitals of Geneva  Geneva Switzerland"},{"name":"Department of Pathology and Immunology, Faculty of Medicine University of Geneva  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Spuls","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Amsterdam University Medical Centre, Amsterdam Public Health, Infection and Immunity University of Amsterdam  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6083-0952","authenticated-orcid":false,"given":"L.","family":"Puig","sequence":"additional","affiliation":[{"name":"Department of Dermatology Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut de Recerca Sant Pau  Barcelona Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.0024"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1580550"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3786"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2020.1754194"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2024.06.001"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11187"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02172-7"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30060430"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12040.x"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2011.590792"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03839-0"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173580"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04520.x"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16915"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16926"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00363-z"},{"key":"e_1_2_14_18_1","unstructured":"FDA.FDA Drug Safety Communication: UPDATE on Tumor Necrosis Factor (TNF) blockers and risk for pediatric malignancy.2011https:\/\/www.fda.gov\/drugs\/drug\u2010safety\u2010and\u2010availability\/fda\u2010drug\u2010safety\u2010communication\u2010update\u2010tumor\u2010necrosis\u2010factor\u2010tnf\u2010blockers\u2010and\u2010risk\u2010pediatric"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030390"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2025.3928"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17010014"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05387-6"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01166-4"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000865"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30362-0"},{"issue":"4","key":"e_1_2_14_26_1","first-page":"643","article-title":"Systematic literature review and meta\u2010analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer","volume":"84","author":"Sebbag E","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.07.027"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01738-4"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00743-9"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00966-4"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2025.2056"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20136"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00512-4"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.04.038"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19520"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14889"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00797-9"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2025.2456532"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071940"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2021.1970706"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.5070\/D327654071"},{"issue":"7","key":"e_1_2_14_42_1","first-page":"2878","article-title":"Psoriatic arthropathy in patients with previous neoplasia: A case series of four patients treated with secukinumab and literature review","volume":"28","author":"Massafra UG","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004308"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2152322"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-023-01306-2"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.5070\/D329160215"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/10781552241269712"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021-0274"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2025.0344"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae013"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12214"},{"key":"e_1_2_14_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.05.006"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1294416"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.03.035"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad081"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14368"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20818"},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19866"},{"key":"e_1_2_14_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llaf172"},{"key":"e_1_2_14_60_1","first-page":"90","article-title":"A 60\u2010week real\u2010world experience with guselkuma in patients with moderate\u2010to\u2010severe plaque psoriasis including patients with malignancy: A retrospective study from Ontario, Canada","volume":"27","author":"Al\u2010Rabai M","year":"2023","journal-title":"J Dermatol Surg"},{"key":"e_1_2_14_61_1","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2022.9282"},{"key":"e_1_2_14_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llaf184"},{"key":"e_1_2_14_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2024.02.019"},{"key":"e_1_2_14_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.600"},{"key":"e_1_2_14_65_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S483166"},{"key":"e_1_2_14_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2024.09.027"},{"key":"e_1_2_14_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000875"},{"key":"e_1_2_14_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.03.029"},{"key":"e_1_2_14_69_1","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2022.117740"},{"key":"e_1_2_14_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00754-4"},{"key":"e_1_2_14_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00685-0"},{"key":"e_1_2_14_72_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S511559"},{"key":"e_1_2_14_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17264"},{"key":"e_1_2_14_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02362-y"},{"key":"e_1_2_14_75_1","doi-asserted-by":"publisher","DOI":"10.1177\/03000605241297551"},{"key":"e_1_2_14_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.09.002"},{"key":"e_1_2_14_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2023.100128"},{"key":"e_1_2_14_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17850"},{"key":"e_1_2_14_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102563"},{"key":"e_1_2_14_80_1","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9924306"},{"key":"e_1_2_14_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.03.039"},{"key":"e_1_2_14_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2024.06.1272"},{"key":"e_1_2_14_83_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00139-2025"},{"key":"e_1_2_14_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.12.003"},{"key":"e_1_2_14_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21867"},{"key":"e_1_2_14_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.07.019"},{"key":"e_1_2_14_87_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S474411"},{"key":"e_1_2_14_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00792-6"},{"key":"e_1_2_14_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2025.03.030"},{"key":"e_1_2_14_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2025.11.057"},{"key":"e_1_2_14_91_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825312"},{"key":"e_1_2_14_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00783-7"},{"key":"e_1_2_14_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15306"},{"key":"e_1_2_14_94_1","doi-asserted-by":"publisher","DOI":"10.1159\/000501993"},{"key":"e_1_2_14_95_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S499658"},{"key":"e_1_2_14_96_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2023.4407"},{"key":"e_1_2_14_97_1","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1204a179"},{"issue":"2","key":"e_1_2_14_98_1","first-page":"23","article-title":"Is Apremilast a safe option in patients with history of melanoma? A case series and a review of the literature","volume":"15","author":"Gambardella A","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_14_99_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"e_1_2_14_100_1","unstructured":"EMA.Janus kinase inhibitors (JAKi)\u2013referral 2023.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/janus\u2010kinase\u2010inhibitors\u2010jaki"},{"key":"e_1_2_14_101_1","unstructured":"FDA.Janus Kinase (JAK) inhibitors: Drug Safety Communication\u2013FDA Requires Warnings about Increased Risk of Serious Heart\u2010related Events Cancer Blood Clots and Death.2021https:\/\/www.fda.gov\/safety\/medical\u2010product\u2010safety\u2010information\/janus\u2010kinase\u2010jak\u2010inhibitors\u2010drug\u2010safety\u2010communication\u2010fda\u2010requires\u2010warnings\u2010about\u2010increased\u2010risk"},{"key":"e_1_2_14_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-024-00869-w"},{"key":"e_1_2_14_103_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02445-w"},{"key":"e_1_2_14_104_1","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2024.141125"},{"key":"e_1_2_14_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-023-00621-6"},{"key":"e_1_2_14_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20553"},{"key":"e_1_2_14_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152341"},{"key":"e_1_2_14_108_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007885"},{"key":"e_1_2_14_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.07.005"},{"key":"e_1_2_14_110_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2025.3059"},{"key":"e_1_2_14_111_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf1329"},{"key":"e_1_2_14_112_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade8520"},{"key":"e_1_2_14_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.70263"},{"key":"e_1_2_14_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20809"},{"key":"e_1_2_14_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20639"},{"issue":"1","key":"e_1_2_14_116_1","article-title":"At the crossroads of TNF alpha signaling and cancer","volume":"17","author":"Manohar SM","year":"2024","journal-title":"Curr Mol Pharmacol"},{"key":"e_1_2_14_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2628"},{"key":"e_1_2_14_118_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020167"},{"key":"e_1_2_14_119_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1145"},{"key":"e_1_2_14_120_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028530"},{"key":"e_1_2_14_121_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01682"},{"key":"e_1_2_14_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110757"},{"key":"e_1_2_14_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22875-w"},{"key":"e_1_2_14_124_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1085458"},{"key":"e_1_2_14_125_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.24.14322"},{"key":"e_1_2_14_126_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062998"},{"key":"e_1_2_14_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2011.07.006"},{"key":"e_1_2_14_128_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3MR0117-033R"},{"key":"e_1_2_14_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1258-8"},{"key":"e_1_2_14_130_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2023-0101"},{"key":"e_1_2_14_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1"},{"key":"e_1_2_14_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01468-7"},{"key":"e_1_2_14_133_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164171"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70634","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.70634","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:17:15Z","timestamp":1790857035000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.70634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":132,"alternative-id":["10.1111\/jdv.70634"],"URL":"https:\/\/doi.org\/10.1111\/jdv.70634","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"2025-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jdv.70634"}}